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UNITED STATES FOOD LAW UPDATE:
LABELING CONTROVERSIES, BIOTECHNOLOGY




This update summarizes significant changes and developments
in food law throughout the first half of 2007. Out of necessity, not
every change is included; rather, this update is limited to significant
changes in national law. This series of updates provides a starting
point for scholars, practitioners, food scientists, and policymakers
determined to understand the shaping of food law in modern soci-
ety. Tracing the development of food law through these updates
also builds an important historical context for the overall develop-
ment of the discipline.
Significant regulatory developments within the context of three
broad categories warrant discussion in this version of the Food Law
Update: food labeling, agricultural biotechnology, and the safety of
imported food. The E. coli outbreaks, discussed in the previous up-
date,' alerted the public to the vulnerability of not only the meat and
poultry supply to foodborne pathogens, but also the most whole-
some of products, fresh produce. This unprecedented outbreak led
to the questioning of the government's ability to oversee the food
supply for its citizens. A series of problems involving contaminated
imported food further shook the public's confidence in the food
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safety system and prompted President Bush to form a task force to
identify and resolve systemic regulatory challenges. The govern-
ment also suffered two significant setbacks related to its policy of
biotechnology regulation, headlined by the inability to identify the
source of rice contamination and the court ordered de-
commercialization of a previously approved genetically engineered
alfalfa variety. Many in the organic and non-genetically engineered
food supply chain considered the alfalfa litigation an important step
in recognizing the impact of genetic engineering on their economic
welfare. Finally, two particular types of labeling claims were the sub-
ject of considerable attention during the first half of 2007. Food
manufacturers, in their drive to differentiate their goods on the
commodity grocery shelves and satisfy the desire of consumers for
healthy, functional foods, succeeded in acquiring another qualified
health claim with marginal scientific support. Meanwhile, other
food processors stepped up challenges to the government's refusal
to finalize rules for the ubiquitous use of the "natural" claim on
food labels.
II. FOOD LABELING
A. FDA Industry Guidance for Labeling Claims
Although many consumers demonstrate a high degree of
awareness of the use of food labels as a means to improve health
through diet, general consumer comprehension of the details of
food labels remains mixed.2 To clarify the regulatory position of the
2. Winning the Claim Game: Confused by Label Claims for Health Benefits for Every-
thing from Walnuts to Corn Oil? Here's How to Read the Fine Print, 25 TuFTS UNIV.
HEALTH & NUTRITION LETTER S1 (Aug 1, 2007) (discussing the health-labeling sys-
tem that, according to some experts, has spun out of control); Susan Bora, Con-
sumer Perspectives on Food Labels, 83 Am. J. CLINICAL NUTRITION 1235S, 1235S (2006
Supp.), available at http://www.ajcn.org/cg/reprint/83/5/1235S.pdf (finding high
consumer awareness of nutrition labels but confusion regarding percent daily value
information and labels overall as too confusing); Andreas C. Drichoutis et al., Con-
sumers' Use of Nutritional Labels: A Review of Research Studies and Issues, 9 ACAD. OF
MKTG. Scl. REV. 1, 1 (2006), available at http://www.amsreview.org/
articles/drichoutisO9-2006.pdf (finding that nutritional labels affect purchasing
behavior for consumers seeking to avoid negative nutrients in food products, al-
though health claims may have mixed purchasing results); Sanjiv Agarwal et al.,
Nutritional Claims for Functional Foods and Supplements, 221 TOXICOLOGY 44, 44-48
(2006) (describing provisions to communicate healthfulness of a food product to
consumers); J. Craig Rowlands & James E. Hoadley, FDA Perspectives on Health
Claims for Food Labels, 221 TOXICOLOGY 35, 35 (2006) (noting that consumers may
[VOL. 3:253
U.S. FOOD LAW UPDATE
Food and Drug Administration (FDA) with respect to the various
categories of labeling claims-health claims,3 structure/function
claims,4 nutrient content claims,5 and dietary guidance6-the Center
for Food Safety and Applied Nutrition issued a guidance letter to
conventional food manufacturers and distributors reminding them
of their responsibilities to ensure accurate food labeling informa-
tion.7 The agency also clarified its position that information dis-
seminated via the Internet, by or on behalf of a regulated company,
could constitute "labeling" under the Federal Food, Drug, and Cos-
metic Act.8 For example, a "labeling" would include information
relating to a product promoted on and available for purchase di-
rectly from the company's website.' In addition, a statement on a
product referring consumers to a specific website with additional
information regarding a claim for the product likely would consti-
tute "labeling."' ° Accordingly, the FDA advised all manufacturers
and distributors to review their respective Internet sites for compli-
ance with FDA regulations."
not be able to distinguish between a nutrient content claim and a health claim);
Food & Drug Admin. (FDA), Questions and Answers, Qualifed Health Claims in Food
Labeling, Report on Effects of Strength of Science Disclaimers on the Communication Im-
pacts of Health Claims, http://www.cfsan.fda.gov/ -dms/qhc-qa.html (last visited Jan.
29, 2008) (discussing results of an FDA study regarding consumer confusion about
qualified health claim labels) [hereinafter FDA Questions and Answers].
3. 21 C.F.R. § 101.14(a)(1) (2007) (defining "health claim" as a statement de-
scribing a relationship between a food or food substance and a disease or health-
related condition).
4. Id. § 101.93(f) (defining "structure/function claim" as a statement describing
the role of a nutrient intended to affect the structure or function of humans); see
also FDA, Structure/Function Claims, http://www.cfsan.fda.gov/-dms/labstruc.html
(last visited Jan. 29, 2008) (describing the FDA's review of structure/function claims
for conventional foods).
5. 21 C.F.R. § 101.13 (2007) (defining "nutrient content claim" as a description
of the level of a nutrient in a particular food in comparison to another food or as a
descriptive term such as free, high, or low).
6. See General Requirements for Health Claims for Food, 58 Fed. Reg. 2,478,
2,487 (Jan. 6, 1993) (codified at 7 C.F.R. pts. 20 and 101) (distinguishing health
claims and dietary guidance statements).
7. CTR. FOR FOOD SAFETY & APPLIED NUTRITION, GUIDANCE FOR INDUSTRY AND
FDA, DEAR MANUFACTURER LETTER REGARDING FOOD LABELING (January 2007),
available at http://www.cfsan.fda.gov/-dms/flguid.html [hereinafter FDA Food
Labeling Letter].
8. Id.; see also 21 U.S.C. § 321(m) (1994) (defining "labeling" as "all labels and
other written, printed, or graphic matter (1) upon any article or any of its contain-
ers or wrappers, or (2) accompanying such article").
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B. Qualified Health Claims
Health claims accompanying conventional food products in-
tended for human consumption "characterize a relationship be-
tween a substance (a specific food component or a specific food)
and a disease or health-related condition, and are supported by sci-
entific evidence."'2 Government sanctioned health claims arose
from the Nutritional Labeling and Education Act of 1990." While
not requiring unanimity, the FDA requires unqualified health claims
to be supported by "significant scientific agreement" among experts
in the area. 4 For several years, the FDA rejected outright all health
claims that failed to meet the significant scientific agreement stan-
dard.
The FDA's eventual authorization of "qualified" health claims
developed, in part, in response to constitutional challenges to the
significant scientific agreement standard. In Pearson v. Shalala,'5 the
United States Court of Appeals for the District of Columbia held
that the agency infringed upon the petitioner's First Amendment
rights when it refused to consider whether a disclaimer might elimi-
nate consumer confusion relating to the proposed health claim that
has some scientific support but was disallowed because the claim
lacked significant scientific agreement.'6 As a result, the FDA, in
December 2002, announced its intention to allow on conventional
foods health claims with qualifying statements regarding the degree
of scientific certainty.'7 In July 2003, the FDA issued further indus-
12. FDA Questions and Answers, supra note 2.
13. See Nutritional Labeling and Education Act of 1990, Pub. L. No. 101-535,
§ 301, 104 Stat. 2,353 (1990). For implementing regulations, see General Require-
ments for Health Claims for Food, 58 Fed. Reg. 2,478 (Jan. 6, 1993) (codified at 21
C.F.R. pts. 20 and 101).
14. FDA, GUIDANCE FOR INDUSTRY, SIGNIFICANT SCIENTIFIC AGREEMENT IN THE
REVIEW OF HEALTH CLAIMS FOR CONVENTIONAL FOODS AND DIETARY SUPPLEMENTS
(Dec. 22, 1999), available at http://www.cfsan.fda.gov/-dms/ssaguide.html.
15. See generally Pearson v. Shalala, 164 F.3d 650 (D.C. Cir. 1999).
16. See id. at 657-58. For a more thorough discussion of Pearson, see Martin
Hahn, Functional Foods: What are They? How are the Regulated? What Claim can be
Made?, 31 AM. J.L. & MED. No. 2-3, 305, 320-22 (2005); and Amber K. Spencer,
Note, FDA Knows Best... or Does It? First Amendment Protection of Health Claims on
Dietary Supplements: Pearson v. Shalala, 15 B.Y.U. J. PUB. L. 87 (2000) (discussing
Pearson and advocating a policy of more rather than less information when con-
fronted with scientific uncertainty).
17. See Guidance for Industry: Qualified Health Claims in the Labeling of Con-
ventional Foods and Dietary Supplements; Availability, 67 Fed. Reg. 78,002 (Dec.
20, 2002) (providing guidance for industry for qualified health claims in the label-
ing for food and dietary supplements).
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try guidance including procedures and criteria for exercise of the
agency's enforcement discretion for qualified claims.'8
Under the current rules, the agency classifies proposed health
claims into one of four categories. Category "A" claims meet the
significant scientific agreement standard'9 and may be used without
qualification.0 Claims in which the agency has a "moderate or good
level of comfort"2' are category "B" and require qualifying language
such as "although there is scientific evidence supporting the claim,
the evidence is not conclusive. "' Category "C" and "D" claims have
"a low level of comfort" or "an extremely low level of comfort,"',
respectively, and stronger accompanying disclaimers. ' As of this
writing, the FDA has approved fifteen petitions for qualified health
claims.5
18. FDA, GUIDANCE FOR INDUSTRY, INTERIM PROCEDURES FOR QUALIFIED HEALTH
CLAIMS IN THE LABELING OF CONVENTIONAL HUMAN FOOD AND HUMAN DIETARY
SUPPLEMENTS, available at http://www.cfsan.fda.gov/-dms/hclmgui3.html [herein-
after FDA INTERIM PROCEDURES].
19. FDA Questions and Answers, supra note 2.
20. See FDA INTERIM PROCEDURES, supra note 18.
21. FDA Questions and Answers, supra note 2.
22. FDA INTERIM PROCEDURES, supra note 18.
23. FDA Questions and Answers, supra note 2.
24. See generally FDA INTERIM PROCEDURES, supra note 18. Level "C" claims re-
quire the following disclaimer: "[s]ome scientific evidence suggests . . .however,
FDA has determined that this evidence is limited and not conclusive." Id. Level
"D" claims, the lowest category allowed by the FDA, require the following dis-
claimer: "[v]ery limited and preliminary scientific research suggests . . .FDA con-
cludes that there is little scientific evidence supporting this claim." Id.
25. FDA, Qualified Health Claims, available at http://www.cfsan.fda.gov/
-dms/lab-qhc.html. The first petition for a qualified health claim arose from a
court order in Pearson v. Shalala, 164 F.3d 650 (D.C. Cir. 1999), directing the FDA
to reconsider a proposed health claim that folic acid reduced the risk of neural tube
defects. In an October 10, 2000 letter of enforcement discretion, the agency stated
its intention to consider the exercise of its enforcement discretion with regard to
the proposed qualified health claims in dietary supplement labeling. FDA, LETTER
REGARDING DIETARY SUPPLEMENT HEALTH CLAIM FOR FOLIC ACID WITH RESPECT TO
NEURAL TUBE DEFECTS, available at http://www.cfsan.fda.gov/-dms/ds-ltr7.html.
The second and third petitions also arose from litigation. See Whitaker.v. Thomp-
son, 248 F. Supp. 2d 1 (D.D.C. 2002). In a May 15, 2001 letter of enforcement
discretion and a November 28, 2000 letter, the FDA agreed to exercise enforce-
ment discretion over the proposed qualified claims that folic acid, vitamin B6, and
vitamin B,, decrease the risk of vascular disease. FDA, Settlement Reached for Health
Claim Relating B Vitamins and Vascular Disease, available at
http://www.cfsan.fda.gov/-dms/ds-hclbv.html; FDA, LETrER REGARDING DIETARY
SUPPLEMENT HEALTH CLAIM FOR FOLIC ACID, VITAMIN B6, AND VITAMIN B12 AND
VASCULAR DISEASE, available at http://www.cfsan.fda.gov/-dms/ds-ltrl2.html. In a
letter of enforcement discretion dated April 1, 2003, the FDA also agreed to con-
2007]
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sider exercising enforcement discretion over a qualified health claim that the con-
sumption of antioxidant vitamins may reduce the risk of certain forms of cancer.
FDA, LETTER REGARDING DIETARY SUPPLEMENT HEALTH CLAIM FOR ANTIOXIDANT
VITAMINS AND RISK OF CERTAIN CANCERS, available at http://www.cfsan.
fda.gov/- dms/ds-Itr34.html.
The Tree Nut Council Research and Education Foundation and the Califor-
nia Walnut Commission, in 2002, filed the fourth set of petitions, seeking authori-
zation for a qualified health claim about the relationship between nuts and coro-
nary heart disease. The FDA responded with a July 14, 2003 letter and a March 9,
2004 letter, in which the agency agreed to exercise enforcement discretion over a
qualified health claim linking consumption of walnuts to a reduced risk of coronary
heart disease. FDA, QUALIFIED HEALTH CLAIMS: LETTER OF ENFORCEMENT
DISCRETION-NUTS AND CORONARY HEART DISEASE (2003), available at
http://www.cfsan.fda.gov/-dms/qhcnuts2.html; FDA, QUALIFIED HEALTH CLAIMS:
LETTER OF ENFORCEMENT DISCRETION-WALNUTS AND CORONARY HEART DISEASE
(2004), available at http://www.cfsan.fda.gov/~dms/qhcnuts3.html.
Dr. Kyl Smith filed the fifth successful petition for a qualified health claim in
2002 relating to the relationship between phosphatidylserine and cognitive function
and dementia. In its letter of enforcement discretion dated November 24, 2004,
the FDA reaffirmed its decision in its May 13, 2003 letter, exercising enforcement
discretion for the requested claims. FDA, LETTER UPDATING THE
PHOSPHATIDYLSERINE AND COGNITIVE FUNCTION AND DEMENTIA QUALIFIED HEALTH
CLAIM (2004), available at http://www.cfsan.fda.gov/-dms/ds-Itr39.html; FDA,
PHOSPHATIDYLSERINE AND COGNITIVE DYSFUNCTION AND DEMENTIA (QUALIFIED
HEALTH CLAIM: FINAL DECISION LETTER) (2003), available at
http://www.cfsan.fda.gov/- dms/ds-Itr36.html.
Wellness Lifestyles, Inc. filed the sixth successful claim. In an April 28, 2003
letter of enforcement discretion, the FDA agreed to consider extending enforce-
ment discretion over a qualified health claim that selenium may reduce the risk of
certain cancers. FDA, SELENIUM AND CERTAIN CANCERS (QUALIFIED HEALTH CLAIM:
FINAL DECISION LETTER), available at http://www.cfsan.fda.gov/-dms/ds-ltr35.html.
Wellness Lifestyles, Inc. and Marteck Biosciences Corporation filed the seventh set
of petitions seeking FDA authorization of a health claim for the consumption of
omega-3 fatty acids and a reduced risk of coronary heart disease. On September 8,
2004, FDA responded to both petitions with two letters of enforcement discretion.
FDA, LETTER RESPONDING TO HEALTH CLAIM PETITION DATED NOVEMBER 3, 2003
(MARTEK PETITION): OMEGA-3 FATTY ACIDS AND REDUCED RISK OF CORONARY HEART
DISEASE, available at http://www.cfsan.fda.gov/-dms/ds-Itr37.html; FDA, LETTER
RESPONDING TO HEALTH CLAIM PETITION DATED JUNE 23, 2003 (WELLNESS PETITION):
OMEGA-3 FATTY ACIDS AND REDUCED RISK OF CORONARY HEART DISEASE, available at
http://www.cfsan.fda.gov/ dms/ds-ltr38.html.
The eighth petition for a qualified health claim, filed by Nutrition 21, Inc. in
2003, involved the relationship between chromium picolinate and a reduced risk of
insulin resistance and therefore type two diabetes. In an August 25, 2005 letter of
enforcement discretion, the FDA concluded there was very limited credible evi-
dence for the qualified health claim, but agreed to consider the exercise of its en-
forcement discretion for the requested claim. FDA, QUALIFIED HEALTH CLAIMS:
LETrER OF ENFORCEMENT DISCRETION-CHROMIUM PICOLINATE AND INSULIN
RESISTANCE, available at http://www.cfsan.fda.gov/-dms/qhccr.html.
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Marine Bio USA, Inc. filed the ninth successful petition for qualified health
claims in 2003. The petition involved the relationship between consumption of
calcium and a reduced risk of hypertension. The FDA responded with a letter of
enforcement discretion dated October 12, 2005. FDA, QUALIFIED HEALTH CLAIMS:
LETTER OF ENFORCEMENT DISCRETION-CALCIUM AND HYPERTENSION; PREGNANCY-
INDUCED HYPERTENSION; AND PREECLAMPSIA, available at http://www.
cfsan.fda.gov/-dms/qhcca3.html. Marine Bio USA, Inc. also succeeded in acquir-
ing the tenth qualified health claim for the relationship between calcium and cer-
tain cancers. In its 2003 petition, Marine Bio requested that the agency authorize a
health claim that calcium may reduce the risk of prostate, colorectal, colon, rectal,
and breast cancers as well as recurrent colon polyps. In a letter of enforcement
discretion dated October 12, 2005, the FDA concluded that there is no credible
evidence to support qualified health claims about calcium and breast or prostate
cancer, but that the FDA would consider exercising enforcement discretion over
qualified health claims about calcium and colon/rectal cancer and colon/rectal
polyps. FDA, QUALIFIED HEALTH CLAIMS: LETTER REGARDING CALCIUM AND
COLON/RECTAL, BREAST, AND PROSTATE CANCERS AND RECURRENT COLON POLYPS,
available at http://www.cfsan.fda.gov/- dms/qhcca2.html.
In 2003, the North American Olive Oil Association filed the eleventh suc-
cessful qualified health claim petition regarding the consumption of monounsatu-
rated fatty acids from olive oil and a reduced risk of coronary heart disease. In a
letter dated November 1, 2004, the FDA stated its intention to consider exercising
enforcement discretion over the requested qualified health claim. FDA, LETTER
RESPONDING TO HEALTH CLAIM PETITION DATED AUGUST 28, 2003:
MONOUNSATURATED FATTY ACIDS FROM OLIVE OIL AND CORONARY HEART DISEASE,
available at http://www.cfsan.fda.gov/ - dms/qhcolive.html.
Fleminger, Inc. submitted the twelfth successful petition for a qualified
health claim in 2004, requesting the FDA to authorize a claim linking the consump-
tion of green tea with a reduced risk of cancer. After a scientific review, the agency
issued a letter of enforcement on June 30, 2005, stating that there is no credible
evidence to support qualified health claims for green tea consumption and a re-
duced risk of gastric, lung, colon/rectal, esophageal, pancreatic, ovarian, and com-
bined cancers. The FDA, however, agreed to consider exercising enforcement
discretion as to claims specifically for green tea and breast and prostate cancer.
FDA, LETTER RESPONDING TO HEALTH CLAIM PETITION DATED JANUARY 27, 2004:
GREEN TEA AND REDUCED RISK OF CANCER HEALTH CLAIM, available at
http://www.cfsan.fda.gov/- dms/qhc-gtea.html.
In 2004, American Longevity, Inc. and the Lycopene Health Claim Coalition
petitioned the FDA for qualified health claims that lycopene from tomatoes reduces
the risk of certain types of cancer, such as prostate cancer. On November 8, 2005,
the FDA issued two letters of enforcement discretion, stating that the current scien-
tific evidence for the proposed qualified health claims relating to the consumption
of tomatoes and/or tomato sauce and reduced risk of cancer is appropriate for
consideration as a qualified health claim, but that claims about the relationship
between the consumption of lycopene and cancer did not have a sufficient scientific
basis to support a qualified health claim. FDA, QUALIFIED HEALTH CLAIMS: LETTER
REGARDING TOMATOES AND PROSTATE, OVARIAN, GASTRIC AND PANCREATIC CANCERS
(AMERICAN LONGEVITY PETITION), available at http://www.cfsan.fda.gov/
-dms/qhclyco.html; FDA, QUALIFIED HEALTH CLAIMS: LETTER REGARDING
2007]
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On March 26, 2007, the agency, despite what some critics con-
tend is little scientific evidence in support,6 approved a qualified
health claim for corn oil.27 Specifically, the qualified health claim
relates consumption of unsaturated fatty acids from corn oil in sub-
stitution for saturated fatty acids while not increasing caloric intake
to a reduced risk of coronary heart disease.2 ' The FDA approved the
qualified claim under its category "D" criteria with relatively strong
limiting language.
The controversy arising from the recent approval of a qualified
health claim for corn oil illustrates the current debate among nutri-
tion policy experts, " and within the FDA," regarding the effective-
ness of the disclaimers and concerns that a proliferation of very
TOMATOES AND PROSTATE CANCER (LYCOPENE HEATH CLAIM COALITION), available at
http://www.cfsan.fda.gov/- dms/qhclyco2.html.
The U.S. Canola Association, in 2006, filed the fourteenth successful petition
for a qualified health claim involving consumption of unsaturated fatty acids in
canola oil and a reduced risk of coronary heart disease. On October 6, 2006, the
FDA responded with a letter of enforcement discretion stating that it would con-
sider extending enforcement discretion for the proposed qualified health claim.
FDA, QUALIFIED HEALTH CLAIMS: LETTER OF ENFORCEMENT DISCRETION-
UNSATURATED FATTY ACIDS FROM CANOLA OIL AND REDUCED RISK OF CORONARY
HEART DISEASE, available at http://www.cfsan.fda.gov/ - dms/qhccanol.html.
ACH Food Companies, Inc. submitted the fifteenth and most controversial
request for a qualified health claim in 2006, for corn oil and a reduced risk of heart
disease. The FDA responded in a March 26, 2007 letter of enforcement discretion
concluding that sufficient scientific evidence existed to warrant enforcement discre-
tion over the requested qualified health claim. FDA, QUALIFIED HEALTH CLAIMS:
LETTER OF ENFORCEMENT DISCRETION-CORN OIL AND CORN OIL-CONTAINING
PRODUCTS AND A REDUCED RISK OF HEART DISEASE, available at
http://www.cfsan.fda.gov/-dms/qhccorno.html. For further discussion of the
corn oil health claim, see infra notes 27-32 and accompanying text.
26. See Karen Ravn, Corn Oil-Good for You?, L.A. TIMES, April 16, 2007, at F3
(quoting Marion Nestle, professor of nutrition at New York University).
27. FDA, QUALIFIED HEALTH CLAIMS: LETTER OF ENFORCEMENT DISCRETION-
CORN OIL AND CORN OIL-CONTAINING PRODUCTS AND A REDUCED RISK OF HEART
DISEASE, supra note 25.
28. Id.
29. Id.
30. See Winning the Claim Game, supra note 2 (noting that in the consumer's
mind, the fine distinctions between disclaimers are often blurred and add to the
confusing maze of health labeling rules, and quoting Professor Tillotson's concerns
that the public will regard the claims as "nothing more than product puffery" with
those firms making a valid attempt at high level research and development to pro-
vide worthwhile health benefits eventually losing out).
31. FDA Questions and Answers, supra note 2 (discussing the FDA's findings that
qualifying statements were "not understood by consumers" and even when under-
stood as intended, resulted in "unexpected effects on consumers' judgments about
the health benefits and overall healthfulness of the product").
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weak claims, even if accompanied by legalistic disclaimers, may
eventually "crowd out" the effectiveness of unqualified, category "A"
health claims and those qualified health claims with higher levels of
scientific support. Although the "corn oil" claim engendered a fair
amount of public criticism this past spring, the FDA is unlikely to
further address this issue via rulemaking in the near term. Rather,
the agency will continue to scrutinize proposed claims, rejecting
those wholly lacking in scientific support. 2
Concerns regarding qualified health claims relate to the larger
issue of products marketed as "functional foods."3 The Institute of
Food Technologists (IFT) defines "functional foods" as "food and
food components that provide a health benefit beyond basic nutri-
tion ... ."' The FDA regulates additives and labeling claims made
for functional foods under the existing regulatory framework for
conventional foods.' The IFT, as well as the Government Account-
ability Office, recommended that the FDA develop and promulgate
regulations or industry guidance to address specifically functional
foods.' On December 5, 2006, the FDA held a public hearing to
gather information regarding regulation of conventional food mar-
keted as functional foods 7 and later extended the comment period
to March 5, 2007.' Future updates will track the agency's progress
with respect to functional food regulation.
C. Defining "Natural" in USDA and FDA Regulated Food Products
For more than three decades, various federal agencies have
grappled with regulating the term "natural" on food labels. Ad-
vances in technology, including new uses for additives otherwise
deemed "natural," pose challenges to existing policies. Consumers
have become increasingly interested in food additives and labels,
32. As of this writing, the FDA has issued letters of denial for at least fifteen
petitions for qualified health claims. See FDA, Qualied Health Claims, supra note
25.
33. Conventional Foods Being Marketed as "Functional Foods"; Public Hearing;
Request for Comments, 71 Fed. Reg. 62,400, 62,401 (Oct. 25, 2006).
34. Id. at 62,401.
35. Id. Moreover, FDA does not consider "functional foods" to be dietary sup-
plements. Id.
36. Id. at 62,403 (Government Accountability Office recommendation); id. at
62,405 (Institute of Food Technologists recommendation).
37. Id. at 62,400 (providing notice of meeting date).
38. Conventional Foods Being Marketed as "Functional Foods"; Extension of
Comment Period, 72 Fed Reg. 694 (Jan. 8, 2007) (extending comment period for
functional food proposed regulations).
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and the food industry seeks to exploit consumers' willingness to pay
for what they perceive as a more wholesome product. Recognizing
this new market paradigm, the United States Department of Agricul-
ture (USDA) Food Safety Inspection Service (FSIS) is reconsidering
its twenty-five-year-old policy and has initiated a formal rulemaking
process for "natural" labels for meat and poultry products. The his-
tory of foot-dragging at developing a regulation may not repeat it-
self, however. The USDA faces an industry lawsuit for its failure to
develop a consistent policy for "natural" claims, including allega-
tions that recent policy changes have favored less-innovative com-
petitors. The FDA also has not been immune to recent controversy
surrounding "natural" claims. Pending before the FDA are two in-
dustry petitions requesting that the FDA work jointly with the FSIS
to develop a uniform policy concerning the term "natural."
1. The History of "Natural" Claim Rulemaking
The Federal Trade Commission (FTC) was the first agency to
attempt regulation of "natural" label claims in the 1970s. " The
agency terminated its rulemaking in 1983, however, concluding that
"natural" claims would continue to be evaluated on a case-by-case
basis."° The Bureau of Alcohol, Tobacco and Firearms followed suit
in 1985." The FDA also attempted to define the term through a
rule in the early 1990s,'2 but ultimately concluded that resource limi-
tations and other agency priorities precluded rulemaking at that
43time.
In 1982, the FSIS established guidance for "natural" label claims
on meat and poultry products, based in part on the FTC recom-
mendations stemming from its aborted rulemaking process of the
early 1980s. Under the guidance system, manufacturers submit la-
39. Proposed Trade Regulation Rule, 39 Fed. Reg. 39,842 (Nov. 11, 1974); Pro-
posed Trade Regulation Rule, 40 Fed. Reg. 23,086 (May 28, 1975); Final Notice
Regarding Proposed Trade Regulation Rule, 41 Fed. Reg. 8,980 (Mar. 2, 1976).
40. Termination of Proposed Trade Regulation; Rule on Food Advertising, 48
Fed. Reg. 23,270 (May 24, 1983).
41. Use of "Natural" in the Labeling and Advertising of Alcoholic Beverages, 50
Fed. Reg. 906, 960-61 (Jan. 8, 1985) (withdrawing the "natural" issue from notice of
proposed rulemaking).
42. Food Labeling: Nutrient Content Claims, General Principles, Petitions, Defi-
nition of Terms, 56 Fed. Reg. 60,421, 60,466 (Nov. 27, 1991).
43. Food Labeling: Nutrient Content Claims, General Principles, Petitions, Defi-
nition of Terms; Definitions of Nutrient Content Claims for the Fat, Fatty Acid, and
Cholesterol Content of Food, 58 Fed. Reg. 2,302, 2,407 (Jan. 6, 1993).
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bels bearing "natural" claims to the FSIS Labeling and Consumer
Protection staff before applying the labeling to products. The FSIS
determines the appropriateness of the label on a case-by-case basis.
As the process evolved, the FSIS developed guidance memos incor-
porated into the FSIS Food Standards and Labeling Policy Book.'
One of these memos-Policy Memorandum 055 (Policy Memo 055)-
governs the pre-market approval process for "natural" labels on
meat and poultry products." Guidance is not contained in formal
regulations.
Policy Memo 055 states that products may bear the "natural"
label if. "(1) the product does not contain any artificial flavor or
flavoring, coloring ingredient, or chemical preservative (as defined
in 21 C.F.R. § 101.22), or any other artificial or synthetic ingredient;
and (2) the product and its ingredients are not more than minimally
processed."" Minimal processing includes traditional methods of
processing or preserving such as "smoking, roasting, freezing, dry-
ing or fermenting," or physical processes that "do not fundamentally
alter the raw product" or which only separate parts from the whole
(e.g., grinding meat or pressing fruit to make juice)."
Manufacturers must explain on the label near the "natural"
claim that the product is considered natural because "it contains no
artificial ingredients, and is minimally processed . . . ."' Policy
Memo 055 allows for exceptions on a case-by-case basis if the pro-
posed ingredient "would not significantly change the character of
the product to the point where it could no longer be considered a
natural product" 9 But, manufacturers must conspicuously identify
the excepted ingredient on the label.' The FSIS judges the "natu-
ral" claim on a contextual basis as well. For example, a "turkey
roast" cannot be called a natural product if it contains beet coloring,
but can still bear the statement "all natural ingredients.""1
44. See Food Safety Inspection Serv. (FSIS), Transcript of Public Meeting, Prod-
uct Labeling: Definition of the Term "Natural" 19-20 (Dec. 12, 2006), available at
http://www.fsis.usda.gov/PDF/NaturalClaimsTranscripts.pdf. [hereinafter FSIS
Transcript].
45. FSIS, FOOD STANDARDS AND LABELING POLICY BOOK (Aug. 2005), available at
http://www.fsis.usda.gov/OPPDE/larc/Policies/LabelingPolicy-Book_082005.pdf
[hereinafter LABELING POLIcY BOOK]. This version contains an explanation of the
policy that was in place prior to the August 2005 changes.




50. LABELING POLICY BOOK, supra note 45, at 116.
51. See FSIS Transcript, supra note 44, at 24.
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In August 2005, the FSIS modified Policy Memo 055 by adding
what quickly became a very controversial addendum. The additional
language stated that "[s]ugar, sodium lactate (from a corn source),
natural flavorings from oleoresins or extractives are acceptable for
'all natural' claims." The new policy also referred to the National
Organic Program's (NOP) National List of Allowed and Prohibited
Substances" for a list of acceptable ingredients allowed for "all natu-
ral" claims.
2. The October 2006 Hormel Petition
In response to the August 2005 changes, Hormel Foods Corpo-
ration filed a petition with the FSIS in October 2006 requesting that
the agency initiate rulemaking procedures to define the term "natu-
ral" and the circumstances under which it can be used.' In the peti-
tion, Hormel advocated placing a formal definition of "natural" in
the FSIS's false or misleading labeling regulations." Hormel argued
that in the absence of a regulation, consumer confusion will con-
tinue to grow.' Hormel cited industry and citizen group efforts to
prevent misleading "natural" claims that result from ambiguous
policies, including the Sugar Association's petition 7 before the FDA
and the Center for Science in the Public Interest's (CSPI) requests
for enforcement actions and threatened lawsuits. 8
52. See LABELING POLICY BOOK, supra note 45; see also Product Labeling: Defini-
tion of the Term "Natural," 71 Fed. Reg. 70,503, 70,504 (Dec. 5, 2006).
53. 7 C.F.R. §§ 205.601-606 (2007).
54. Hormel Foods Corporate Services, LLC Petition to FSIS, Re: Issuance of a
Rule Regarding Natural Label Claims (October 9, 2006), available at
http://www.fsis.usda.gov/PDF/Petition NaturalLabelClaims 1.pdf [hereinafter
Hormel Petition].
55. See generally id.; see also 9 C.F.R. § 317.8 (2007) (meat) and § 381.129 (poul-
try).
56. Hormel Petition, supra note 54, at 5-8.
57. Sugar Ass'n Petition to FDA, Re: Definition of the Term "Natural" For Mak-
ing Claims on Food and Beverages Regulated by the Food and Drug Administration
(February 28, 2006), available at http://www.cspinet.org/new/pdf/sugar-
fdapetition.pdf [hereinafter Sugar Ass'n Petition]. For a more thorough discus-
sion of the sugar industry's petition, see infra notes 86-94 and accompanying text.
58. The Center for Science in the Public Interest (CSPI) sued Kraft for its "natu-
ral" claim on Capri Sun drinks sweetened with high-fructose corn syrup, an ingredi-
ent the CSPI alleged was not "minimally processed" under the 1982 Policy. Kraft
eventually agreed to drop the claim. See Complaint, Linda Rex v. Kraft Foods, Inc.
(Fla. Palm Beach County Ct. Jan. 8, 2007), available at http://cspinet.org/
new/pdf/complaint.pdf. Cadbury Schweppes also agreed to drop a similar "all
natural" claim after the CSPI threatened suit. See Press Release, CPSI, CPSI to Sue
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Hormel's petition identified internal inconsistencies in the new
FSIS policy. Hormel noted that while one part of the policy states
that "natural" foods cannot contain any artificial flavors or flavor-
ings, coloring ingredient, or chemical preservatives, newly added
language allowed ingredients from the NOP National List.' There-
fore, it is unclear whether "natural chili" could be labeled as such if
it was colored with an ingredient on the NOP list such as beet pow-
der.' Hormel further argued that allowing the use of synthetic in-
gredients from the National List was inconsistent with the prohibi-
tion against artificial flavor or color."1 Hormel concluded by arguing
that sodium lactate is a chemical preservative, and its inclusion as an
allowable ingredient in products labeled as "natural" was inconsis-
tent with previous policies.62
3. Formal Rulemaking Process for "Natural" Claims
In December 2006, the FSIS announced that it would remove
the sodium lactate provision from Policy Memo 055 due to the con-
troversy it caused within the regulated community.' The FSIS
added language to Policy Memo 055 indicating that sodium lactate
would be judged on a case-by-case basis pending a final rule on the
term "natural."' The reference to the NOP National List was also
removed. The FSIS explained that it only added the reference to
the NOP National List to help manufacturers locate sources for in-
gredients that could be used in "natural" products, but that the
statement confused manufacturers by implying that all organic in-
gredients could be used in "natural" products-a situation that the
FSIS states is not allowed.'
The FSIS concluded that it would initiate formal rulemaking in
an attempt to resolve the sodium lactate and other escalating con-
troversies stemming from Policy Memo 055 and the August 2005
Cadbury Schweppes Over "All Natural" 7-Up (May 11, 2006),
http://www.cspinet.org/new/200605111.html (last visited Feb. 20, 2008).
59. Hormel Petition, supra note 54, at 9.
60. Id.
61. Id.
62. Id. at 11-12.
63. Product Labeling: Definition of the Term "Natural," 71 Fed. Reg. 70,503,
70,504 (Dec. 5, 2006) (providing notice of the Hormel petition and requesting pub-
lic comments).
64. LABELING POLICY BOOK, supra note 45.
65. Id.
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changes.' The FSIS also acknowledged several allegations contained
in the Hormel petition, including arguments that the August 2005
policy changes made it difficult for manufacturers to maintain a
level playing field, and that some manufacturers would take advan-
tage of perceived inconsistencies in the policy and manipulate ex-
ceptions in a way that would undercut the effectiveness of the "natu-
ral" label and regulatory intent.
67
The FSIS held a public meeting' to discuss certain issues raised
by the Hormel petition, including consumer expectations of a
"natural" label, the types of food processing methods commonplace
today versus twenty-four years ago when the policy on "natural"
claims was established, and whether a "minimally processed" stan-
dard should remain a requirement of the "natural" label. 9 The pub-
lic hearing also sought to address whether ingredients or processes
that would otherwise disqualify a product from bearing the "natu-
ral" label but would enhance food safety-for example, sodium lac-
tate or high pressure processing-should be excepted.7' The FSIS
also solicited public comment through January 2007, and later ex-
tended the comment period through March 5, 2007.7
The FSIS has yet to issue any further statement or rule regard-
ing the hearing and public comments. Some written comments and
oral testimony focused on the value to the regulated community of
transparency and consistency in the FSIS determinations, and on
the fact that case-by-case determinations have resulted in varied
meanings of the word "natural." 71 Other comments have noted the
emphasis in existing policy on processing methods and ingredients,
despite growing consumer awareness and concern over how animals
66. 71 Fed. Reg. at 70,504.
67. Id.
68. The hearing was held on December 12, 2006. See FSIS Transcript, supra note
44.
69. 71 Fed. Reg. at 70,504.
70. Id.
71. Product Labeling: Definition of the Term "Natural," 72 Fed. Reg. 2,257 (Jan.
18, 2007). The comments can be found at http://www.fsis.usda.gov/OPPDE/
Comments/2006-0040/ (last visited Mar. 26, 2008).
72. See Sara Lee Food & Beverage Corp., Citizen Petition: requesting the Food
Safety & Inspection Service to Develop requirements for the Use of the Term
"Natural" Consistent with the Food & Drug Administration, Mar. 5, 2007, available
at http://www.fsis.usda.gov/OPPDE/Comments/2006-00400?2006-0400-24.pdf.
73. N. Am. Natural Casing Ass'n, Comments, Docket No. FSIS-2006-0400: Prod-
uct Labeling: Definition of the term "Natural," Mar. 5, 2007, available at
http://www.fsis.usda.gov/OPPDE/Comments/2006-0040-25.pdf.
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are raised.' One commenter noted that the FSIS should work with
the Agricultural Marketing Service (AMS) for claims involving natu-
rally-raised livestock.' Many commenters expressed concern that
Hormel's claim-that sodium lactate is a chemical preservative be-
cause it is not minimally processed or because it results in food
preservation-might result in future preclusion of other ingredients
that the FSIS has previously allowed as preservatives for naturally-
labeled food.'
4. The Hormel Foods Lawsuit
Despite the FSIS's initial attempts to redefine "natural," in Sep-
tember 2007, Hormel Foods Corporation filed a complaint in the
U.S. District Court for the District of Columbia alleging that the
USDA has failed to rescind approval of "natural" label claims on
certain meat and poultry products marketed by Hormel's competi-
tors that contain sodium lactate and potassium lactate, even after
issuing letters indicating the contrary.77 Hormel claimed that the
USDA's failure to rescind approval of "natural" claims results in
misbranding8 under the Federal Meat Inspection Act (FMIA) and
the Poultry Products Inspection Act (PPIA), and contravenes the
74. See, e.g., Farm Sanctuary, Inc., Comments, Docket No. FSIS-2006-0400: Prod-
uct Labeling: Definition of the term "Natural," Jan. 10, 2007, available at
http://www.fsis.usda.gov/OPPDE/Comments/2006-0040-1 1.pdf.
75. See, e.g., Am. Ass'n of Meat Processors, Comments, Docket No. FSIS-2006-
0400: Product Labeling: Definition of the term "Natural," Jan. 11, 2007, available at
http://www.fsis.usda.gov/OPPDE/Comments/2006-0040-13.pdf.
76. Nat'l Meat Ass'n, Comments, Docket No. FSIS-2006-0400: Product Labeling:
Definition of the term "Natural," Dec. 12, 2006, available at http://
www.fsis.usda.gov/OPPDE/Comments/2006-0040-17.pdf.
77. See generally Complaint, Hormel Foods Corp. v. USDA, No. 07-1724 (D.D.C.
Sept. 26, 2007) [hereinafter Hormel Complaint]. At the same time that the FSIS
announced that it was rescinding the note to Policy Memo 055 regarding sodium
lactate, it sent letters to thirty members of the regulated community regarding the
use of lactates in their products. Id. at 15-17. The FSIS requested that users of
lactates show, within sixty days, that use of lactates below the 2% threshold was only
for flavoring purposes and that lactates in their product do not function as pre-
servatives. Id. at 16. Thirty members of the industry responded. Id. at 17. The
FSIS has stated that it will not rescind any natural label permissions that have been
issued for products containing sodium lactate or potassium lactate, and will instead
pursue resolution through the rulemaking process. Id. at 17-18.
78. "Misbranding" under the Federal Meat Inspection Act or Poultry Products
Inspection Act occurs if a label "bears or contains any artificial flavoring, artificial
coloring, or chemical preservative, unless it bears labeling stating that fact .... " 21
U.S.C. § 601(h)(11); § 458(n)(11) (2000) (emphasis added).
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FSIS's Policy Memo 055, because products bearing the claim: (1)
contain less than 2% of sodium lactate and potassium lactate for
preservative purposes, (2) do not display the fact that the product
contains preservatives on the label, and (3) are not minimally proc-
essed.79 Hormel further asserted that the USDA "act[ed] arbitrarily,
capriciously, or contrary to law" under the Administrative Proce-
dure Act (APA) by not rescinding the "natural" label approvals ac-
cording to its own findings, even though it stated that it would do so
in letters to the regulated community.' Hormel contended that the
USDA further violated the APA by failing to conduct notice and
comment rulemaking before making its decision not to rescind the
"natural" labels." Hormel also argued that the USDA's failure
amounts to abdication of its statutory responsibilities under the
FMIA and the PPIA.'
Hormel sought a declaration from the court that the USDA has
approved "natural" labels for products that contain sodium or po-
tassium lactate acting as a chemical preservative and, moreover, that
the agency must require a disclaimer in these instances acknowledg-
ing use of the chemical preservatives and that the product is not
"minimally processed."' Hormel also sought a declaration that the
USDA violated the APA by failing to provide the rationale for acting
inconsistently with its prior determination that products labeled as
"natural" cannot contain sodium lactate or potassium lactate for
preservative purposes, for its failure to rescind approval of such la-
bels, and for failing to conduct notice and comment rulemaking
before making the decision to grant an exemption from what Hor-
mel claims is misbranding under the governing statutes.' Hormel
asked the court to enjoin the USDA from approving such products
for sale without a label stating that they are preserved using sodium
lactate or potassium lactate, and that existing approvals be re-
scinded.'
79. Hormel Complaint, supra note 77, at 20.
80. Id. at 21.
81. Id. at 22.
82. Id.
83. Id. at 22-23.
84. Hormel Complaint, supra note 77, at 23.
85. Id. at 23-24.
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5. Petitions Before the FDA Regarding "Natural" Claims
As of this writing, two petitions are pending before the FDA re-
questing action relating to use of the term "natural" on food labels.
The first petition was filed by the Sugar Association on February 28,
2006, requesting that the FDA Commissioner "establish rules and
regulations governing the definition of 'natural' before a natural
claim can be made on food and beverages regulated by the FDA." '
The Sugar Association asked the FDA to "maintain consistency
across Federal agencies and define the term 'natural' based on the
definition provided in the United States Department of Agriculture
(USDA) Food Standards and Labeling Policy Book," and proposed a
policy mirroring that of Policy Memo 055."7 The petition noted that
even though consumer interest in natural labels has grown, the lack
of a concise FDA rule regarding the claim has "engendered a great
deal of ambiguity. " 's The petition further explained that the explo-
sion of food technologies since the FDA last attempted to address
the "natural" claim issue in the early 1990s warrants "strict [FDA]
guidelines that ensure that 'natural' claims do not mislead the grow-
ing number of consumers who value and wish to purchase natural
products."89
The Sugar Association petition focused on the "minimally
processed" standard contained in Policy Memo 055 and how starch-
based sweeteners are so fundamentally altered as to disqualify their
use in products labeled as "natural. " " The Association contended
that this should be true regardless of whether the transformation
process is triggered through enzymatic or chemical means, or
whether the resulting substance otherwise exists in nature." The
Sugar Association cited three cases decided by the National Adver-
tising Division of the Better Business Bureau in which "natural"
claims were found misleading, thus evidencing the vulnerability of
consumers and the importance of regulatory bodies in preventing
misleading claims.' The FDA docket"3 for the Petition indicated that
86. Sugar Ass'n Petition, supra note 57.
87. Id. at 1-2.
88. Id. at 3.
89. Id. at 4.
90. Id. at 4-5.
91. Sugar Ass'n Petition, supra note 57, at 6-7.
92. Id. at 7-8.
93. USDA, Docket No. 2006P-0094: Define the term natural before a natural claim can
be made on foods and beverages regulated by the FDA, http://www.fda.gov/
ohrms/dockets/dockets/06pOO94/06pOO94.htm (last visitedJan. 28, 2008).
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as of August 2006, the FDA had taken no action on the Petition be-
cause of resource limitations and competing agency priorities."
On April 9, 2007, the Sara Lee Corporation filed a Petition with
the FDA requesting that the agency work jointly with the FSIS to
adopt a uniform policy for "natural" claims. 5 The Petition noted
that recent FSIS changes to Policy Memo 055 have created uncer-
tainty, particularly for products containing sodium lactate." Sara
Lee argued that use of sodium lactate is consistent with "natural"
claims, and that the FDA should adopt a policy that maximizes food
safety. 7 Sara Lee advocated against formal rulemaking, arguing that
flexibility is necessary to judge the context in which an ingredient is
used. The FDA docket, as of this writing, did not indicate that any
action has been taken on the Petition.98
With the FDA allocating resources to other priorities such as
food safety,' the agency may choose once again to ignore the issue.
This may, unfortunately, not be the best strategy. Due to the ex-
panding market presence of "natural" products and increasing sci-
entific complexity of natural-derived ingredients, food regulatory
agencies, as well as the FTC, should coordinate their efforts now to
finalize a workable standard that will facilitate industry compliance
and eliminate consumer confusion.
III. BIOTECHNOLOGY
A. Genetically Engineered Rice Commingles with Rice Intended for Hu-
man Consumption
In December 1998, Aventis CropScience commenced field test-
ing of a new genetically engineered rice variety, LLRice601, resistant
94. Letter from Barbara Schneeman, Dir. of Nutritional Products, Labeling, &
Dietary Supplements Office of the FDA, to Andrew Briscoe, CEO of the Sugar
Ass'n (Aug. 3, 2006), available at http://www.fda.gov/ohrms/dockets/
dockets/06p0094/06p-0094-etOO01-vol2.pdf.
95. Sara Lee Corp., Citizen Petition Requesting the FDA to Develop Require-
ments for the Use of the Term "Natural" Consistent with the USDA's Food Safety
and Inspection Service (April 9, 2007), available at http://www.fda.gov/
ohrms/dockets/dockets/07p0l4 7/07p-0147-cpO001-toc.htm.
96. Id. at 8-9.
97. Id. at 10.
98. See USDA, Docket No. 2007P-0147: Develop Requirements for the use of the
Term Natural Consistent with USDA's Food Safety and Inspection Serv.,
http://www.fda.gov/ohrms/dockets/dockets/07pO147/07pO147.htm (last visited
Jan. 30, 2008).
99. See infra Section IV.
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to the herbicide glufosinate, marketed under the brand name "Lib-
erty." Although it did not seek regulatory approval for the commer-
cial release of LLRice601, Aventis did obtain approval from the
United States Department of Agriculture (USDA) Animal & Plant
Health Inspection Service (APHIS) for two nearly identical genetic
engineering events, LLRice06 and LLRice62.ln As field trials were
wrapping up, Bayer acquired Aventis and formed Bayer Crop-
Science. Bayer, however, did not petition the USDA for deregula-
tion of LLRice601 variety.
In January of 2006, Riceland, the nation's largest rice coopera-
tive, discovered trace amounts of genetically engineered DNA in the
2005 Midwest long-grain rice crop."' According to Bill Reed, Rice-
land Vice President of Public Affairs, the company initially believed
that the genetically engineered material was from "residual frag-
ments of genetically engineered corn or soybeans resulting from use
of common public transportation systems."'0" Because the geneti-
cally engineered material was present in such small quantities, a lab
was unable to determine its origin.10'3 Riceland collected additional
samples in May, and "[a] significant number tested positive for the
Bayer trait.""" Bayer confirmed that the genetically engineered ma-
terial was the LLRice601.105
The USDA learned of the incident on July 31, 2006 and an-
nounced to the public that genetically engineered rice was present
in the food supply on August 18, 2006, after conducting a safety
review and approving a method to test for LLRice601. '06 Japan im-
mediately banned long-grain rice imports from the United States
and the European Union implemented a testing regime for all rice
originating from the United States.' 7 Within days, the first lawsuits
by farmers were filed against Bayer and Riceland. On December
19, 2006, the Judicial Panel of Multi District Litigation transferred
100. See AgrEvo USA Co., Availability of Determination of Nonregulated Status for
Rice Genetically Engineered for Glufosinate Herbicide Tolerance, 64 Fed. Reg. 22,595
(April 27, 1999).
101. See Statement from Bill J. Reed, Vice President for Public Affairs, Riceland







106. Andrew Pollack, Unapproved Rice Strain Found in Wide Area, N.Y. TIMES, Aug.
22, 2006, at C2.
107. Id.
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thirteen of the pending LLRice601 actions to the Eastern District of
Missouri in St. Louis.' 8 The court further noted the filing of six
other actions and eight potential "tag along" actions not consoli-
dated with the original thirteen, which presumably seek recovery for
the price impacts attributable to lost exports.'" In addition, a Ger-
man food processing firm, Rickmers, filed a breach of contract ac-
tion against Riceland for the delivery of rice in 2005 and 2006 that
contained genetically engineered material (an alleged non-
conforming good)."'
Based on Bayer's assertion of similarity to the previously de-
regulated LLRice06 and LLRice62, the USDA subsequently deregu-
lated LLRice601."' Determining the cause of the contamination,
however, proved to be a larger challenge for the agency and the rice
industry. After discovery of the LLRice601 contamination, the USA
Rice Federation commenced a seed-testing program to identify
other contamination from genetic engineering. The Arkansas State
Plant Board notified the USDA that up to thirty percent of the 2006
certified rice samples of CL131, a long grain rice variety, tested posi-
tive for a genetically engineered gene similar to the LL601 rice."'
Subsequently identified as LLRice604, only three acres (by a single
producer) were planted due to the early identification and response
by APHIS."' The crop was destroyed without incident."' Despite its
extensive investigation, the USDA eventually announced that it was
unable to determine how the commingling occurred and declined
any regulatory enforcement action against Bayer."'
108. Transfer Order, In re LLRice601 Contamination Litigation, MDL Docket
No. MDL-1811 (E.D. Mo. 2006), available at http://www.llrice601
contaminationlitigation.com/caseinformation.html#mdl.
109. Id.
110. Complaint, Rickmers Reismiiehle Gmbh. v. Riceland Foods, Inc., Case No. 4-
07-CV00000733-JMM (E.D. Ark. Aug. 21, 2007) (on file with the author).
111. See Bayer CropScience, Availability of an Environmental Assessment and a
Preliminary Decision for an Extension of a Determination of Nonregulated Status
for Rice Genetically Engineered for Glufosinate Herbicide Tolerance, 71 Fed. Reg.
53,076 (Sept. 8, 2006); see also FDA, Biotechnology Consultation, Note to the File
BNF No. 00063 (Aug. 30, 2000), available at http://www.cfsan.fda.gov/
rdb/bnfm063.html (stating that the agency had no further questions regarding
human consumption of genetically engineered varieties LLRice06 and LLRice62).




114. Id. at 5-6.
115. See id. at 1.
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Many of the class action plaintiffs in the ongoing rice litiga-
tion ' raise issues similar to the allegations in the Starlink corn
products liability litigation,1 1 7 which resulted in a significant settle-
ment for the nation's corn growers."8 Future updates in this journal
will track the rice litigation and any subsequent impact on agricul-
tural biotechnology regulation.
This is not the first legal debate regarding genetically engi-
neered rice and coexistence concerns. On May 16, 2007, the USDA
approved Ventria Bioscience's permit application for field testing of
rice genetically engineered to produce a pharmaceutical compound,
specifically, lactoferrin, lysozyme, or serum albumin."9 The location
of the approved field test is Geary County, Kansas.' 0 At this time,
there is no commercial rice production at any location in Kansas.''
This is in contrast to Ventria's other proposed field trials of its ge-
netically engineered rice. Previous permit applications for Califor-
nia and Missouri, two of the nation's largest commercial rice pro-
ducing states, were met with stiff opposition from the rice industry
due to fears of commingling with non-genetically engineered rice
produced for the domestic and international markets.' Although
the USDA eventually granted permits for experimental trials of the
genetically engineered rice in Missouri,'22 public opposition moti-
116. See In re Genetically Modified Rice Litigation, Court Papers,
http://www.bayerricelitigation.com/ (follow Court Papers hyperlink) (last visited
May 23, 2008) (containing a collection of complaints filed against Riceland and
Bayer CropScience alleging that Bayer had a regulatory duty (Count I) as well a
general duty (Count II) to test, grow, store, transport and dispose of the LLRice601
variety in a manner that would not result in contamination of the rice market and
that Bayer allegedly breached those duties by failing to adequately oversee or con-
trol its field test growers, directly resulting in damages to plaintiffs).
117. Kramer v. Aventis CropScience USA Holding Inc., 212 F. Supp. 2d 828 (N.D.
11. 2002).
118. For a thorough discussion of the Starlink litigation and settlement, see Don-
ald L. Uchtmann, StarlinkM-A Case Study of Agricultural Biotechnology Regulation, 7
DRAKEJ. AGMiC. L. 159 (2002).
119. See Availability of an Environmental Assessment and Finding of No Signifi-
cant Impact for a Proposed Field Release of Rice Genetically Engineered to Express
lactoferrin, Lysozyme, or Serum Albumin, 72 Fed. Reg. 27,539 (May 16, 2007).
120. Id. at 27,540.
121. Id.
122. A. Bryan Endres, Coexistence Strategies in a Biotech World: Exploring Statutory
Grower Protections, 13 Mo. ENVTL. L. & POL'VY REv. 206, 224-32 (2006) (discussing
Ventria's attempts to conduct field trials).
123. Availability of Environmental Assessment and Finding of No Significant
Impact for Field Tests of Genetically Engineered Rice Expressing Lysozyme, 70
Fed. Reg. 37,077 (June 28, 2005); Availability of Environmental Assessment and
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vated Ventria to change locations to Kansas, thereby diffusing at
least some criticism related to food purity and adding another chap-
ter to the coexistence debate between conventional and genetically
engineered agricultural products. 24
B. Genetically Engineered Alfalfa Removed from Market
In April 2004, Monsanto Company and Forage Genetics Inter-
national submitted a petition requesting the deregulation of its gly-
phosate-tolerant alfalfa.1 25 APHIS prepared an Environmental As-
sessment (EA) and solicited public comment on the assessment and
deregulation petition. 6 Many comments related to possible "con-
tamination" of organic or conventionally grown alfalfa with geneti-
cally modified varieties during pollination. 7 Alfalfa, unlike many
commodity crops, relies on bees for pollination and therefore tradi-
tional segregation distances may not be effective.2 Farmers wishing
to sell conventional or organic alfalfa feared that they would be un-
able to meet the domestic market's contractual requirements for
genetic purity or the export market's demand for only approved
genetic events.' 9 Despite these concerns, APHIS issued a determi-
nation of nonregulated status for the herbicide tolerant alfalfa,'0
Finding of No Significant Impact for Field Tests of Genetically Engineered Rice
Expressing Lactoferrin, 70 Fed. Reg. 37,079 (June 28, 2005).
124. See generally USDA, DRAFT GUIDANCE FOR APHIS PERMrrs FOR FIELD TESTING
OR MOVEMENT OF ORGANISMS WITH PHARMACEUTICAL OR INDUSTRIAL INTENT, at 18-24
(Jan. 9, 2007), available at http://www.aphis.usda.gov/brs/pdf/Pharma-
Guidance.pdf (providing guidance to facilitate coexistence).
125. Petition for Determination of Nonregulated Status: Roundup Ready Alfalfa
(Medicago sativa L.) Events J101 and J163, Petition No. 04-AL-116U, available at
http://www.aphis.usda.gov/brs/aphisdocs/04-1 1001p.pdf.
126. APHIS, Environmental Assessment: Monsanto Co. & Forage Genetics Int'l
Petition 04-110-01p for Determination of Non-regulated Status for Roundup Ready
Alfalfa Events J101 and J163 (Oct. 2004), available at http://
www.aphis.usda.gov/brs/aphisdocs/04_11001p-pea.pdf; see also Monsanto Co. &
Forage Genetics International; Availability of Petition & Environmental Assessment
for Determination of Nonregulated States for Alfalfa Genetically Engineered for
Tolerance to Herbicide Glyphosate, 69 Fed. Reg. 68,300 (Nov. 24, 2004).
127. Geertson Seed Farms v.Johanns, No. C 06-01075 CRB, 2007 WL 518624, *2
(N.D. Cal. Feb. 13, 2007) [hereinafter Geertson 1].
128. APHIS, Response to Comments to the Finding of No Significant Impact for
the Determination of Non-regulated Status for Roundup Ready Alfalfa Events J101
and J163, at 2, available at http://www.aphis.usda.gov/brs/aphisdocs2/
041100 1pcom.pdf [hereinafter Comments to Alfalfa FONSI].
129. Id. at 1-2.
130. See Monsanto Co. & Forage Genetics Int'l; Availability Determination of
Nonregulated Status, 70 Fed. Reg. 36,917 (June 27, 2005).
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and farmers planted an estimated 200,000 acres of Roundup Ready
alfalfa for forage and another 20,000 acres for seed in 2006.' Some
alfalfa growers, the Sierra Club, and various farm and consumer
organizations challenged the APHIS decision in the Northern Dis-
trict of California.
In pleadings before the court, APHIS acknowledged the poten-
tial coexistence problems. It reasoned, however, that stewardship
efforts on the part of farmers growing conventional alfalfa could
keep any commingling below the applicable thresholds. 2 With re-
spect to contamination of organic alfalfa production, APHIS con-
cluded that because organic operators already had to implement a
production system that would avoid cross-pollination with neighbor-
ing, non-organic farmers, the deregulation decision would be
unlikely to have a significant environmental impact.' The govern-
ment, in similar agency actions, repeatedly has resolved the question
of who should be responsible for preserving the integrity of a non-
genetically modified (conventional or organic) harvest in favor of
the farmer adopting the new, genetically engineered technology,
regardless of the amount of disruption it may cause on established
farming practices.'"
The court in Geertson noted that while APHIS based its "no sig-
nificant impact" decision on its conclusion that it is organic and
conventional farmers who should ensure that contamination does
not occur, APHIS failed to "identify a single method that an organic
farmer can employ to protect his crop from being pollinated by a
bee that travels from a nearby genetically engineered seed farm,
even assuming the [organic] farmer maintains a 'buffer zone."'1 " In
addition, the court found that the potential economic or financial
impacts suffered by conventional and organic farmers directly result
from the deregulation of genetically engineered alfalfa and that
APHIS's conclusion of "no significant impact" simply was not con-
vincing." Accordingly, the court granted the plaintiffs' motion for
131. See Geertson Farms v. Johanns, No. C 06-01075 CRB, 2007 WL 1302981, *3
(N.D. Cal. May 3, 2007) [hereinafter Geertson II].
132. Comments to Alfalfa FONSI, supra note 128, at 2.
133. Id.
134. See APHIS, Decision on Monsanto Petition 04-125-O1P Seeking a Determina-
tion of Nonregulated Status for Bt cry3Bbl Insect Resistant Corn Line MON 88017,
at 18-19, available at http://www.aphis.usda.gov/brs/aphisdocs/04-12501p_
pea.pdf (stating that there will be no impact on organic farmers from commerciali-
zation of a new genetically engineered corn variety).
135. Geertson I, supra note 127, at *6.
136. Id.
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summary judgment on the NEPA claim and ordered APHIS to pre-
pare a full Environmental Impact Statement (EIS).'37 On May 3,
2007, the court permanently enjoined future planting of Roundup
Ready alfalfa pending completion of the EIS and a decision on the
deregulation petition, but declined to enjoin the harvesting of al-
ready-planted seed and hay.' 38 On August 13, 2007, Monsanto Com-
pany filed a notice of appeal of the injunction.
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The Geertson decision is a significant benchmark for further le-
gal challenges to the express regulatory assumption that organic and
conventional producers must bear the full burden of segregation to
avoid undesirable commingling prior to delivery. To the extent that
the government will require future petitioners seeking deregulation
of genetically engineered crops to undertake coexistence measures,
organic and conventional producers may experience lower produc-
tion costs and fewer marketing problems related to biotechnology.
Of course, these impacts may be long-term and slight, depending
upon the degree of government oversight, market demands, and
consumers' sustained preference for organic or conventionally pro-
duced foodstuffs.
IV. FOOD SAFETY DEVELOPMENTS
A. Follow-Up on Fresh Produce E. coli Outbreaks
The last update in this journal chronicled the government's re-
sponse to the E. coli 0157:H7 pathogen outbreak in fresh spinach
and lettuce.4 As is often the case, highly publicized events trigger
not only immediate agency action, but also regulatory reaction in
the form of revisions or additions to existing programs of oversight.
The Food and Drug Administration (FDA) released results of its
joint investigation (conducted with the Centers for Disease Control
and Prevention, the United States Department of Agriculture
137. Id. at *12. Geertson was decided just a few days after a ruling on another case
challenging APHIS's approval of field trials of genetically engineered grass. See Int'l
Ctr. for Tech. Assessment v. Johanns, 473 F. Supp. 2d 9 (D.D.C. 2007) (vacating
APHIS's denial of a noxious weed petition for genetically engineered grass and
granting summary judgment on plaintiffs' NEPA claims alleging that APHIS failed
to assess properly potential impacts of the field trials).
138. See Geertson II, supra note 131.
139. Jacqui Fatka, Monsanto to Appeal Biotech Alfalfa Ruling, FEEDSTUVFS, August
20, 2007, at 1, available at http://fdsmagissues.feedstuffs.com/fds/
Pastssues/FDS7934/fds0 l_7934.pdf.
140. Endres, supra note 1, at 104-07.
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(USDA) Animal and Plant Health Inspection Service (APHIS), and
various California agencies) into the causes of the 2006 E. coli spin-
ach outbreak.'' Although the agencies were able to identify the en-
vironmental risk factors and the farms most likely linked to the out-
break, they were unable to conclusively determine the origin of the
contamination.'2
The FDA also held two public hearings in the spring of 2007 to
solicit data and other scientific information regarding current prac-
tices in the production and processing of fresh produce.4 Despite
a proliferation of FDA-issued good agricultural practices (GAPs) and
good manufacturing practices (GMPs),'" the agency expressed con-
cern that outbreaks continued to occur and it sought information
on the implementation and effectives of its prior guidance, as well as
opportunities to further reduce risks of foodborne illness related to
fresh produce.4 In March 2007, the FDA also finalized its Guide to
Minimize Microbial Food Safety Hazards of Fresh-cut Fruits and Vegeta-
bles.'46 As with all industry guidance, however, it does not set bind-
ing requirements, but outlines the agency's current perspective on
the topic and recommends that firms adopt food safety practices
tailored to their specific operations. '7 Whether the FDA's hearing
will result in modification of the guidance document remains to be
seen. Private litigation related to the outbreak, however, may be
winding down. The Los Angeles Times has reported that the farm
and two processing companies linked to the spinach outbreak
141. Press Release, FDA, FDA Finalizes Report on 2006 Spinach Outbreak (Mar.
23, 2007), available at http://www.fda.gov/bbs/topics/NEWS/2007/
NEW01593.html.
142. Id.
143. FDA, Safety of Fresh Produce; Public Hearings; Request for Comments, 72
Fed. Reg. 8,750, 8,750-51 (Feb. 27, 2007) (providing notice of hearings and back-
ground information on food safety and fresh produce).
144. See id. at 8,752-53 (describing current GAPs and GMPs such as the Guide to
Minimize Microbial Food Safety Hazards of Fresh-cut Fruits and Vegetables, FDA
Food Code, current GMPs in 21 C.F.R. part 110, and the Produce Safety From
Production to Consumption: 2004 Action Plan to Minimize Foodborne Illness As-
sociated with Fresh Produce Consumption).
145. Id. at 8,753.
146. Draft Final Guidance for Industry: Guide to Minimize Food Safety Hazards
for Fresh-Cut Fruits and Vegetables; Availability; Agency Information Collection
Activities; Submission for Office of Management and Budget Review; Comment
Request, 72 Fed. Reg. 11,364 (Mar. 13, 2007).
147. FDA, GUIDE TO MINIMIZE MICROBIAL FOOD SAFETY HAZARDS OF FRESH-CUT
FRUITS AND VEGETABLES 3 (Oct. 26, 1998), available at http://www.cfsan/fda/gov/
acrobat/prodguid.pdf.
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reached confidential settlements with families of three of the indi-
viduals who died from consuming the contaminated food.'48
B. Imports and the Food Safety System
In 2006, the United States exported agricultural products val-
ued at almost $71 billion.'49 During that same year, the United
States imported over $65 billion of agricultural products,'" up from
only $47 billion in 2003.'"' This rapid growth in imported food and
agricultural products has stressed the fragile food safety system.
Physical inspection of every food product entering the United States
would exhaust the resources of the food safety agencies and "bring
international trade to a standstill."'52 Striking the right balance be-
tween targeted inspections and general surveillance, however, is a
difficult proposition. In early 2007, a series of problematic imports
from China shocked the food safety system and prompted the
President to establish an Interagency Working Group on Import
Safety.
5 3
On March 17, 2007, the FDA announced the recall of pet food
manufactured by Menu Foods, Inc." Nine cats died during routine
taste trials conducted by the company and consumers reported the
death of an additional five pets.'55 At the time of the recall, Menu
Foods was unable to identify the source of the problem.'5 The FDA
eventually identified the suspected contaminant as melamine in rice
protein concentrate used as an ingredient in some pet foods.57 The
148. Mary Engel, Lawsuits over 3 E. coli Deaths Settled, L.A. TIMES, Apr. 23, 2007, at
Metro 4.
149. USDA, Foreign Agricultural Trade of the United States: Monthly Summary,




152. The White House, Fact Sheet: Import Safety Action Plan: Increasing Protection of
American Consumers (Nov. 6, 2007), available at http://www.whitehouse.gov/news/
releases/20071107-7.html [hereinafter Import Safety Action Plan Fact Sheet].
153. See THE WHITE HOUSE, ExEcuTIvE ORDER: ESTABLISHING AN INTERAGENCY
WORKING GROUP ON IMPORT SAFETY (July 18, 2007), available at
http://www.whitehouse.gov/news/releases/2007/07/20070718-4.html.
154. Press Release, FDA, Recall of Pet Foods Manufactured by Menu Foods, Inc.




157. Press Release, FDA, FDA's Update on Tainted Pet Food (April 22, 2007),
available at http://www.fda/gov/bbs/topics/NEWS/2007/NEW01615.htnl.
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source of the product was a Chinese firm, Binzhou Futian Biological
Technology.'6 Concurrently, the California Department of Food
and Agriculture announced that it had detected melamine in urine
from hogs, a result of feed contamination.'6 The USDA and the
FDA subsequently announced that swine fed the adulterated food
would be prohibited from entering the food supply and offered
compensation to producers for depopulation and disposal efforts.'"
The agencies later also tracked some melamine contamination to
wheat gluten imported from China and used as feed in poultry"'
and aquaculture operations."'
Immediately following the pet food and animal feed contamina-
tion scares, the FDA detected toxic contaminants in toothpaste
manufactured in China.'62 In June 2007, targeted sampling by the
FDA of seafood imported from China found farm-raised seafood
contaminated with drug residues from antimicrobial agents not ap-
proved for aquaculture use in the United States.'" As a result, the
agency imposed broader import controls on all farm-raised catfish,
basa, shrimp, dace, and eel from China.'65 During the same month,
the Chinese government closed 180 food plants after inspectors un-
158. Id.
159. Id.
160. Press Release, FDA, Joint News Release: FDA and USDA Determine Swine
Fed Adulterated Product (April 26, 2007), available at http://www.fda.gov/bbs/
topics/NEWS/2007/NEW01618.html.
161. Press Release, FDA, Joint Update: FDA/USDA Trace Adulterated Animal
Feed to Poultry (April 20, 2007), available at http://www.fda/gov/bbs/
topics/NEWS/2007/NEW01621.html. During the FDA/USDA investigation, the
agencies discovered that pet food was contaminated by wheat gluten and rice pro-
tein concentrate that contained melamine. Scraps of pet food were distributed
later to farms and added to swine and poultry feed. Press Release, FDA,
FDA/USDA Joint News Release: Scientists Conclude Very Low Risk to Humans
from Food Containing Melamine (May 7, 2007), available at
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01629.html.
162. Press Release, FDA, USDA Clears Swine for Processing (May 15, 2007),
available at http://www.fda.gov/bbs/topics/NEWS/2007/NEW01635.html.
163. Press Release, FDA, FDA Advises Consumers to Avoid Toothpaste from
China Containing Harmful Chemical (june 1, 2007), available at
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01646.html (warning consum-
ers of the presence of diethylene glycol in several brands of toothpaste manufac-
tured in China).
164. Press Release, FDA, FDA Detains Imports of Farm-Raised Chinese Seafood
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covered more than 23,000 food safety violations.'" Much of the
problem stemmed from the aggressive competitiveness of small
firms using industrial chemicals, banned dyes, and other illegal in-
gredients to cut costs."7 A culture of corruption and bribery may
also permeate the Chinese food and drug industry, as the former
head of the national food and drug agency recently received a death
sentence for accepting bribes and approving substandard drugs."
An agricultural minister is also on trial for endorsing food products
in exchange for bribes. 69
In response to the recalls of various foods due to contaminated
ingredients, the FDA sent a letter reminding food manufactures of
their legal responsibilities regarding safe, unadulterated food.'70 In
addition to government oversight at the border, the FDA empha-
sized that it remains the responsibility of the importing firms to en-
sure safety of their products and that they should implement verifi-
cation procedures with all ingredient suppliers. 7'
As noted above, President Bush created the Interagency Work-
ing Group on Import Safety to coordinate the government's efforts
to ensure a safe food supply and recommend regulatory modifica-
tions. On September 10, 2007, the Working Group presented the
President with a Strategic Framework to increase import safety, an
element of which is a three-part FDA Food Protection Plan. The
plan proposed a science- and risk-based approach of prevention,
intervention, and response to ensure a safe food supply. 2 The next
edition of this update will detail the FDA's implementation of its
action plan.
C. Bovine Spongiform Encephalopathy
First identified in a cattle herd in the United Kingdom, Bovine
Spongiform Encephalopathy (BSE) is a neurodegenerative disease





170. Letter from FDA to Food Manufacturers Regarding Legal Responsibilities
for the Safety of Food Ingredients (May 4, 2007), available at
http://www.cfsan.fda.gov/- dms/protltr.html.
171. Id.
172. See Import Safety Action Plan Fact Sheet, supra note 152.
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that is progressive, incurable, and fatal.17' Linked to a human variant
of Creutzfeldt-Jacob Disease, BSE has spread from the United King-
dom to at least twenty other countries. 17' The discovery of a BSE-
infected cow in the United States resulted in the closure of impor-
tant beef export markets, including Japan and South Korea."5
Following the discovery of BSE-infected cattle in the United
States, the USDA established a testing and surveillance program, as
well as feeding restrictions.' 7' The USDA adopted a policy of testing
only the highest risk animals, rather than all cattle.'77 Due to the
disease's incubation period, only rarely do cattle younger than thirty
months show any signs of disease; 78 however, most cattle in the
United States are slaughtered at less than twenty-four months old.'
9
Therefore, the USDA asserted that any BSE testing of typical slaugh-
ter-age cattle "offers no food safety value" and is "likely to produce
false negative results." °
Creekstone Premium Beef (Creekstone), a supplier of premium
beef, sought to conduct is own testing of all cattle to recover its lost
export markets and constructed a laboratory for BSE testing at its
beef processing facility, sent its employees to France for training on
testing procedures, and requested USDA approval to purchase and
use the testing kits from the same company supplying test kits to the
USDA, Japan, and other countries.'8' The USDA denied Creek-
stone's request, stating that the sale and use of BSE test kits would
be restricted to only state- and USDA-operated laboratories.'" The
USDA's basis for the decision was the Virus-Serum-Toxin Act
(VSTA), which requires a permit to import and places restrictions
on "biological products."'" Creekstone challenged the decision in
the United States District Court for the District of Columbia.
In Count I of Creekstone's complaint, it argued that the inclu-
sion of diagnostic tests as regulated biological products exceeded




176. See Gregory Berlowitz, Note, Food Safety v. Promotion of Industry: Can the
USDA Protect Americans from Bovine Spongiform Encephalopathy?, 2006 U. ILL. L. REv
625 (2006) (describing the USDA's response to BSE).
177. Creekstone, 517 F. Supp. 2d at 10.




182. Creekstone, 517 F. Supp. 2d at 11 (citing APHIS notice No. 04-08).
183. Id.
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the jurisdiction of the VSTA because such tests are neither analo-
gous to viruses, serums or toxins, nor used in the treatment of do-
mestic animals.'" Count II asserted that even if the VSTA applied to
some diagnostic tests, the BSE test kit is not subject to VSTA juris-
diction as the test is not a virus, serum, toxin, or analogous product,
nor is it intended for use in the treatment of domestic animals.
18
With respect to Count I, the court gave great deference to the
USDA's interpretation of the statutory terms and held that the
agency could regulate diagnostic tests." The court, however, re-
fused to defer to the agency's factual argument that "BSE test kits
are used for treatment" of a disease. 87 As noted above, "there is no
treatment for BSE and, moreover, the test kits are used only on
animals that are dead."" Accordingly, the court entered an order
reversing the USDA's decision." The USDA subsequently filed a
notice of appeal.
V. CONCLUSION
Food safety issues, as in the second half of 2006, occupied sig-
nificant public and agency attention through the summer of 2007,
with many questioning the efficacy of the nation's import inspection
system. The safety of the global food supply chain will remain a
source of continued concern. In addition to safe, wholesome food,
demand by American consumers for functional foods continued to
grow with food processors seeking ways to differentiate their prod-
ucts with government sanctioned labeling claims. Continued con-
sumer allure to these claims, however, may well depend on in-
creased government scrutiny and vigilance among competitors to
weed out frivolous labeling claims-a problem analogous to preserv-
ing the integrity (and market power) of the organic label.
184. Id. at 12.
185. Id.
186. Id. at 14.
187. Creekstone, 517 F. Supp. 2d at 16.
188. Id.
189. Id. at 17.
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